|
|
 | | | |
- close
- close
- close
- close
Intelgenx Technologies (IGXT) |
QUOTE AND NEWS
Globe Newswire
Feb 14
Comment
SAINT LAURENT, Quebec, Feb. 14, 2012 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCBB:IGXT) ("IntelGenx") today announced that it has entered into an exclusive agreement with Edgemont Pharmaceuticals, LLC ("Edgemont") for the commercialization
Marketwire
Nov 15
Comment
NEW YORK, NY -- (Marketwire) -- 11/15/11 -- Shares throughout the biotechnology sector have been exceptionally volatile of late as developments regarding government approvals, litigation and shockingly disappointing earnings elicit large movements in
Marketwire
Nov 7
Comment
LOS ANGELES, CA -- (Marketwire) -- 11/07/11 -- In an exclusive interview, Horst G. Zerbe, Ph.D., President and CEO of IntelGenX Corporation (OTCBB: IGXT) shares his thoughts on the firm's pending U.S. regulatory decision involving the drug candidate
Marketwire
Aug 2
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 08/02/11 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx") today announced that Pillar5 Pharma Inc. ("Pillar5") successfully passed a pre-approval inspection by the U.S. Food and Drug
Marketwire
Jan 4
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 01/04/11 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx") today announced that the United States District Court of Delaware has ruled in favor of IntelGenx regarding claim construction for the
Marketwire
Nov 29
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 11/29/10 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx") today announced that it has acquired exclusive rights to, and ownership of, INT0010, an improved formulation of THC (dronabinol) for
Marketwire
Sep 24
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 09/24/10 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx" or the "Company") announced today that at the Company's Annual General Meeting on June 3, 2010, the Security Holders of the
Marketwire
Sep 2
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 09/02/10 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx") today announced the completion of a pilot study that indicates that IntelGenx has successfully developed a novel oral film, INT007,
Marketwire
Aug 30
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 08/30/10 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) ("IntelGenx") and RedHill Biopharma Ltd., an Israeli corporation ("RedHill") today announced that they have entered into a co-development and
Marketwire
Aug 27
Comment
SAINT LAURENT, QUEBEC -- (Marketwire) -- 08/27/10 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX) (OTCBB: IGXT) ("IntelGenx" or "the Company") today announced that it has closed a private placement offering of 6,500,000 units (the "Units") at
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
